Showing results (441-450 of 550) with videos related to

Sort By:
Pageof 55
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 18, 2002
Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of alphavbeta3-antagonists in rat: limited role of P-glycoproteinT Prueksaritanont, Y Meng, B Ma, et al.
The American Journal of Physiology|June 11, 1999
A marathon run increases the susceptibility of LDL to oxidation in vitro and modifies plasma antioxidantsM L Liu, R Bergholm, S Mäkimattila, et al.
The Journal of Biological Chemistry|June 15, 1992
Expression and regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic miceM L Liu, A L Olson, W S Moye-Rowley, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 23, 2004
Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and manB K Wong, Y Sahly, G Mistry, et al.
Human & Experimental Toxicology|September 26, 2013
Effect of DNA damage response by quinazolinone analogue HMJ-38 on human umbilical vein endothelial cells: evidence for γH2A.X and DNA-PK-dependent pathwayJ-H Chiang, J-S Yang, C-C Lu, et al.
The Journal of Biological Chemistry|May 5, 1993
Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic miceA L Olson, M L Liu, W S Moye-Rowley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolitesB K Wong, D DeFeo-Jones, R E Jones, et al.
Oncogene|May 22, 2001
Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic miceM L Liu, M A Shibata, F C Von Lintig, et al.
Zhonghua Yi Xue Za Zhi|March 21, 2020
[Analysis of immunological characteristics of dermatomyositis patients with myocardial involvement]Y H Li, Y Du, L Li, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|April 30, 2025
[Clinicopathological features of early-stage lung adenocarcinomas with co-occurrence of MET exon 14 skipping mutation and gene amplification]Y Y Liu, S F Wu, X D Liu, et al.
Pageof 55